Saw Palmetto-induced Pancreatitis
- 1 June 2006
- journal article
- case report
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 99 (6) , 611-612
- https://doi.org/10.1097/01.smj.0000215642.76198.44
Abstract
Saw palmetto is a frequently used botanical agent in benign prostatic enlargement (BPH). Although it has been reported to cause cholestatic hepatitis and many medical conditions, Saw palmetto has not been implicated in acute pancreatitis. We report a case of a probable Saw palmetto induced acute hepatitis and pancreatitis. A 55-year-old reformed alcoholic, sober for greater than 15 years, presented with severe non-radiating epigastric pain associated with nausea and vomiting. His only significant comorbidity is BPH for which he intermittently took Saw palmetto for about four years. Physical examination revealed normal vital signs, tender epigastrium without guarding or rebound tenderness. Cullen and Gray Turner signs were negative. Complete blood count and basic metabolic profile were normal. Additional laboratory values include a serum amylase: 2,152 mmol/L, lipase: 39,346 mmol/L, serum triglyceride: 38 mmol/L, AST: 1265, ALT: 1232 and alkaline phosphatase was 185. Abdominal ultrasound and magnetic resonance cholangiography revealed sludge without stones. A hepatic indole diacetic acid scan was negative. Patient responded clinically and biochemically to withdrawal of Saw palmetto. Two similar episodes of improvements followed by recurrence were noted with discontinuations and reinstitution of Saw Palmetto. Simultaneous and sustained response of hepatitis and pancreatitis to Saw palmetto abstinence with reoccurrence on reinstitution strongly favors drug effect. "Natural" medicinal preparations are therefore not necessarily safe and the importance of detailed medication history (including "supplements") cannot be over emphasized.Keywords
This publication has 7 references indexed in Scilit:
- Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literatureJournal of Internal Medicine, 2001
- Saw Palmetto Extracts for Treatment of Benign Prostatic HyperplasiaJAMA, 1998
- Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaThe Prostate, 1998
- Protracted Cholestatic Hepatitis after the Use of ProstataAnnals of Internal Medicine, 1997
- Serenoa repens (Permixon®)Drugs & Aging, 1996
- The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open studyCurrent Therapeutic Research, 1994
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984